ANZGOG COMMITTEE & TRIAL MEETINGS WEDNESDAY, 26th MARCH Time Session

2014 Combined Scientific Meeting
Progress through collaboration and innovation
ANZGOG COMMITTEE & TRIAL MEETINGS
WEDNESDAY, 26th MARCH
Time
Session
Location
10.00am-12.30pm
ANZGOG Board of Directors Meeting
Mt Ainslee Room
1.00pm-3.00pm
Tumour Type Working Groups Meeting
Murrumbidgee, Black Mountain
& Mt Ainslee Rooms
3.30pm-5.30pm
Research Advisory Committee Meeting I
Murrumbidgee, Black Mountain
& Mt Ainslee Rooms
THURSDAY, 27th MARCH
Time
Session
Location
7.30am-8.20am
ECHO Meeting (closed meeting)
Assembly Room
12.30pm-1.30pm
OUTBACK Trial Management Committee Meeting
Assembly Room
2.30pm-3.30pm
Consumer & Community Committee Meeting
Assembly Room
5.30pm-6.00pm
REZOLVE TMC Meeting
Assembly Room
FRIDAY, 28th MARCH
Time
Session
Location
7.30am-8.20am
Quality Assurance Meeting
Promenade Cafe
7.30am-8.20am
Fundraising Committee Meeting
Promenade Cafe
12.30pm-1.30pm
ICON 8 Meeting
Assembly Room
SATURDAY, 29th MARCH
Time
Session
Location
7.00am-8.20am
Research Advisory Committee Meeting II
Assembly Room
7.30am-8.20am
Study Coordinators Committee Meeting
Promenade Cafe
15
2014 Combined Scientific Meeting
Progress through collaboration and innovation
WORKSHOPS
WEDNESDAY, 26th MARCH
Time
Session
Location
12.00pm-2.00pm
ANZGOG Clinical Research Ideas Starter Workshop
Both ANZGOG & ASGO members invited to attend
PRESENTED BY: PROF MARTIN STOCKLER, NHMRC Clinical Trials Centre
Assembly
Room
The aim of this workshop is to help participants develop good ideas that can be
turned into successful clinical research studies. The optimal approach to improving
cancer management is based on integrating rationally designed interventions with
the full range of established treatment modalities including surgery, irradiation,
anticancer drugs, supportive and psychosocial care. This presentation will consider
strategies, frameworks, and rules of thumb for turning intuitive clinical questions
into successful clinical studies.
2.00pm-5.00pm
ASGO Mock OSCE & Exam Workshop
For ASGO Fellows
Session Chair: Dr Julie Lamont
Assembly
Room
1.00pm-5.30pm
ANZGOG Study Coordinators Workshop
Audit Readiness: Building in Quality Through Harmonisation and Process Improvement
Session Chair: Ms Sue Brew
GUEST SPEAKER: MS ELEANOR ALLAN
Federation
North
The workshop will provide an understanding of the key components of a Quality
System and the practical considerations in developing your own systems and
processes for conduct of your clinical trials. A good Quality System will help to
ensure you comply with regulatory requirements, increase efficiency and ensure
that your trials are set up and run correctly from the start. The best preparation
for an audit or monitoring visit is to ensure that you are audit ready from the
outset with quality and efficiency built into every stage of your trial. There will be
hands-on experience in identifying key gaps in your current processes, techniques
for developing SOPs, and ways of increasing collaboration with your partners in
ANZGOG trials. You will learn the basics of mapping processes and how to use that
map as the foundation for developing standard operating procedures.
You will also gain experience in identifying bottlenecks, timewasters and problems
in key processes by analysing the process map and develop strategies that you
can implement to prevent these issues. The workshop will include a discussion
session with colleagues from the NHMRC CTC to create an action plan for improving
processes and increasing quality for ANZGOG studies.
3.30pm-5.30pm
ANZGOG Brachytherapy Workshop - Part I
Session Chair: Dr Pearly Khaw
INTERNATIONAL GUEST SPEAKER: ASSOC PROF AKILA VISWANATHAN
Sponsored by:
The use of brachytherapy for gynecologic malignancies has evolved dramatically
in the past decades, specifically with regard to the integration of 3D imaging. An
overview of image-guided approaches and the published literature for MR- and CTbased brachytherapy will be discussed. Issues affecting cervical cancer
brachytherapy in the U.S. will be outlined. Specifically, the development of ABS
guidelines for brachytherapy will be reviewed. How guidelines have influenced
health care will be presented. Criteria for guideline versus for consensus statement
development will be detailed.
16
Gallery Room
2014 Combined Scientific Meeting
Progress through collaboration and innovation
WORKSHOPS
THURSDAY, 27th MARCH
Time
Session
Location
1.30pm-2.30pm
ANZGOG Consumers Workshop
How consumers add benefit to the clinical trials process
Session Chair: Ms Karen Livingstone
GUEST SPEAKER: MS LEONIE YOUNG, Chair, ANZBCTG Consumer Advisory Panel
Followed by Consumer & Community Committee Meeting 2.30pm-3.30pm
Assembly
Room
3.30pm-5.30pm
ANZGOG Nurses Workshop
Session Chair: Ms Judy Eddy
Mt Ainslee
Room
Discussion will focus on options for Gynaecological Oncology Nurses Special
Interest Groups with the other organisations including the International
Gynaecologic Cancer Society as well as managing a consistent multidisciplinary
team approach for gynaecological cancer treatment.
FRIDAY, 28th MARCH
3.30pm-5.30pm
ANZGOG Brachytherapy Workshop - Part II
Session Chair: Dr Pearly Khaw
INTERNATIONAL GUEST SPEAKER: ASSOC PROF AKILA VISWANATHAN
Gallery Room
Sponsored by:
3.30pm-5.30pm
NATIONAL OVARIAN ACTION PLAN WORKSHOP (Invitation only)
Part I - gynaecological oncologists
Session Chair: Ms Alison Amos, CEO, Ovarian Cancer Australia
Co Chair: Ms Alison Evans, Zest Health Strategies
Mt Ainslee
Room
Sponsored by:
The workshop is hosted by Ovarian Cancer Australia (OCA) and Zest Health
Strategies to inform the development of a National Action Plan for Ovarian Cancer
Research in Australia. The plan will guide research priorities and investment in
Australia to improve the quality of life and survival of women with ovarian cancer.
OCA seeks the opinion and insights of key stakeholders in the ovarian cancer
field through active participation in the workshop. The program will include
discussion of field audit outcomes including review and priority setting as well as
recommendations for future research and funding strategies.
SATURDAY, 29th MARCH
1.30pm-5.30pm
NATIONAL OVARIAN ACTION PLAN WORKSHOP (Invitation only)
Part II - Other cancer specialities (non ASGO members)
Session Chair: Ms Alison Amos, CEO, Ovarian Cancer Australia
Co Chair: Ms Alison Evans, Zest Health Strategies
Federation
North
Ballroom
Sponsored by:
17
2014 Combined Scientific Meeting
Progress through collaboration and innovation
THE PROGRAM
WEDNESDAY, 26th MARCH
Time
Session
6.30pm-9.00pm
WELCOME RECEPTION | HYATT COURTYARD
THURSDAY, 27th MARCH
Time
Session
8.30am-8.40am
OFFICIAL WELCOME
DR ALISON BRAND & ASSOC PROF ROB ROME
Federation Ballroom
8.30am-12.30pm
JOINT PLENARY SESSION 1
Session Co-chairs: Assoc Prof Peter Sykes & Miss Orla McNally
Federation Ballroom
8.40am-9.20am
PROF LYNETTE DENNY
Keynote Address: Research in gynaecological cancers - a global perspective
Outline 01
9.20am-10.00am
PROF JONATHAN LEDERMANN
Keynote Address: ICON6 and updates on anti-angiogenic Rx in ovarian cancer
Outline 02
Sponsored by:
10.00am-10.30am
10.00am-10.15am
10.15am-10.30am
ANZGOG Tumor Working Groups Report - What trials should we be doing next?
DR MICHELLE VAUGHAN - Chair, Endometrial Group
ASSOC PROF PHILIP BEALE - Co-Chair, Ovarian Group
10.30am-11.00am
Morning Tea | Exhibition Area
11.00am-11.15am
ANZGOG Tumor Working Groups Report - What trials should we be doing next?
ASSOC PROF ANNE HAMILTON - Chair, Cervix Group
11.15am- 11.30am
ASSOC PROF CLARE SCOTT
Rare Tumour Research Report from CGIC
11.30am-12.30pm
12.30pm-1.30pm
18
Clinical Trials Update
PROF MICHAEL FRIEDLANDER, Director of Research & other Principal Investigators
1. ANZGOG 1103: PI | Danny Rishkin
2. ICON8: PI | Andrew Dean
3. OUTBACK: PI | Linda Mileshkin
4. Paragon: PI | Michael Friedlander
5. PORTEC-3: PI | Linda Mileshkin
6. REZOLVE: PI | Katrin Sjoquist
7. Symptom Benefit: PI | Michael Friedlander
Lunch | POSTER & TRADE SESSION | Exhibition Area
Outline 03
Outline 03
Outline 04
Outline 05
2014 Combined Scientific Meeting
Progress through collaboration and innovation
THE PROGRAM
THURSDAY, 27th MARCH
Time
Session
1.30pm-3.00pm
CONCURRENT SESSIONS
ANZGOG PRESENTATIONS
Session Chair: Dr Michelle Vaughan
Federation North Ballroom
ASGO FELLOWS PRESENTATIONS
Session Chair: Dr Julie Lamont
Federation South Ballroom
1.30pm-1.45pm
DR MATTHEW STROTHER (NZ)
Outline 06
Rational Dosing of Carboplatin : The
Clinical Pharmacologic Basis of Dose Determination
and a Growing Gap in the Literature
1.45pm-2.00pm
DR ANDREW DEAN (WA)
Molecular profiling/biomarkers
Outline 07
2.00pm-2.30pm
PROF DAVID BOWTELL (VIC)
Molecular analysis of ovarian cancer
Outline 08
2.30pm-2.40pm
PROF MICHAEL FRIEDLANDER (NSW)
Outline 09
Hormonal therapies in Gynaecological Cancer
2.40pm-2.50pm
PROF PETER FULLER (VIC)
Outline 10
Hormone Receptors in Gynaecological Cancer
2.50pm-3.00pm
Questions
1 MURAD AL AKER:
Abs 01
Laparoscopic excision of a retroperitoneal mass
in a recurrent stage III-C ovarian cancer: Video presentation.
2 ANNE VAN ALTENA:
Abs 02
Optimize epithelial ovarian cancer treatment in the
eastern part of the Netherlands.
3 GEMMA BLAIN:
Abs 03
Outcomes for women presenting with high grade pap
smears - implications for “see and treat”
4 YVETTE IUS:
Abs 04
A Retrospective Review of the Role of High Risk HPV DNA
Testing as a Test of Cure Post-Treatment for Cervical
Intraepithelial Neoplasia
5 ADAM PENDLEBURY:
Abs 05
Paraneoplastic factor eight deficiency
6 RACHEL O’SULLIVAN:
Abs 06
Management and survival outcomes in women with uterine
papillary serous carcinoma in the Hunter New England
Region of NSW.
7 SUZANNE STAINER:
Abs 07
A prospective audit of sentinel node biopsy for vulval
carcinoma in Australia and New Zealand – reporting
outcomes to date
8 HELEN GREEN:
Abs 08
Splenectomy for ovarian cancer: technique, indications,
complications and outcomes.
3.00pm-3.30pm
Afternoon Tea | Exhibition Area
3.30pm-4.00pm
ANZGOG EXTRA BIOLOGICALLY FOCUSSED ABSTRACTS (ASGO Members Welcome)
Session Chair: Assoc Prof Linda Mileshkin
Federation North Ballroom
1 ANNA DE FAZIO:
Low-grade serous ovarian cancer: A wolf in sheep’s clothing?
2 SHUNIT ARMON:
Comparing Biological Pathways between Normal Fallopian Tube epithelium (NFT) and invasive high
grade epithelial serous ovarian carcinoma (EOC).
3 VALERIE HEONG:
Developing targeted approaches to C5 high-grade serous ovarian cancer (HG-SOC) through novel patient
derived xenografts (PDX)
4.00pm-5.30pm
Abs 10
Abs 11
ANZGOG NEW CONCEPTS PRESENTATION (ASGO Members Welcome)
Session Chair: Assoc Prof Linda Mileshkin
Federation North Ballroom
1 ALISON BRAND:
Selective Targeting of Adjuvant Therapy for EndometrialCancer: The STATEC Trial
2 ANNE HAMILTON:
A randomised trial of Denosumab versus placebo to reduce the incidence of pelvic insufficiency fracture
in women receiving whole pelvis irradiation for pelvic malignancy
3 DAVID BOWTELL:
Genomic mechanisms underlying long-term response to treatment in serous ovarian cancer
4 DAVID BOWTELL:
Targeting molecular subsets of high grade serous cancer
5 JEFF GOH:
Neo-adjuvant chemotherapy for early stage cervical carcinoma
6 PETER SYKES:
The Diagnostic and Prognostic Utility of Telomere Maintenance Mechanism Biomarkers in Malignant
Uterine Smooth Muscle Tumours
7.00pm11.00pm
Abs 09
CONFERENCE DINNER | Old Parliament House
Sponsored by:
Abs 12
Abs 13
Abs 14
Abs 15
Abs 16
Abs 17
2014 Combined Scientific Meeting
Progress through collaboration and innovation
THE PROGRAM
FRIDAY, 28th MARCH
Time
Session
8.30am-10.00am
JOINT PLENARY 2 - CHALLENGES OF OBESITY IN GYAECOLOGICAL ONCOLOGY
Session Co-Chairs: Assoc Prof David Allen & Dr Pearly Khaw
Federation Ballroom
Sponsored by:
PROF MATTHEW WATT
Science of obesity
Outline 11
DR SIVAKUMAR GANANADHA
General Bariatric procedures and when best to refer
Outline 12
9.05am-9.20am
DR DIANA ADAMS
Tackling the Obesity - Endrometrial Tsunami
Outline 13
9.20am-9.50am
ASSOC PROF AKILA VISWANATHAN
Keynote Address: Challenges of treating obese patients using radiotherapy
Outline14
8.30am-8.50am
8.50am-9.05am
Sponsored by:
9.50am-10.00am
Questions
10.00am-10.30am
PROF JOHN MCNEIL
Role of registries in relation to trials and research
10.30am-11.00am
Morning Tea | Exhibition Area
11.00am-11.45am
ANZGOG & ASGO - Highlighted Abstracts of Multidisciplinary Interest
Session Co-Chairs: Assoc Prof Linda Mileshkin & Assoc Prof David Allen
1. RHONDA FARRELL:
Lymphadenectomy in early stage high-risk endometrial cancer: clinical characteristics and
outcomes in an Australian cohort.
2. ORLA MCNALLY:
Sentinel lymph node biopsy in apparently low stage Endometrial Cancer: A feasibility study from
two gynaecological oncology centres.
3. KATE WEBBER:
OvQuest: living after the diagnosis and treatment of ovarian cancer. Preliminary results from an
internet-based survey
4. MICHAEL FRIEDLANDER:
Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian
cancer - Final Results of Stage 1 of GCIG Symptom Benefit Study
11.45am-12.30pm
THE DEBATE
Gynaecological Oncologists should not be given the keys to the drug cabinet
Session Chair: Dr Jane McNeilage
Dr Alison Brand, Prof Michael Friedlander, Dr Michelle Vaughan, Prof Michael Quinn,
Dr Geraldine Goss, Dr Geoff Otton
12.30pm-1.30pm
Lunch | POSTER & TRADE SESSION | Exhibition Area
20
Outline 15
Abs 18
Abs 19
Abs 20
Abs 21
2014 Combined Scientific Meeting
Progress through collaboration and innovation
THE PROGRAM
FRIDAY, 28th MARCH
Time
Session
1.30pm-3.00pm
ANZGOG PRESENTATIONS (ASGO Members welcome or optional free afternoon)
Session Chair: Assoc Prof Linda Mileshkin
Federation Ballroom
ASGO MEMBERS
FREE AFTERNOON
1.30pm-2.15pm
ANZGOG ABSTRACT PRESENTATIONS
Session Chair: Assoc Prof Linda Mileshkin
1 DAVID MIZRAHI:
Abs 22
An exercise intervention during chemotherapy for women with recurrent ovarian cancer
2 PEARLY KHAW:
Abs 23
PET findings in women with endometrial cancer referred for adjuvant radiotherapy
3 CARMINIA LAPUZ:
Abs 24
Survival and patterns of failure in FIGO stage 1B node positive cervix cancer treated
with curative intent
4 KAILASH NARAYAN:
Abs 25
Survival, patterns of failure and prognostic factor analysis in node positive endometrial
cancer patients treated with curative intent.
1.30pm-3.00pm
National Portrait Gallery
2.15pm-3.00pm
ANZGOG PRESENTATION TO MEMBERS
Session Chair: Dr Alison Brand, ANZGOG Chair
- Consumer presentation
- Outreach activities
- Presentation of Awards
3.00pm-3.30pm
Afternoon Tea | Exhibition Area
3.30pm-5.30pm
CONCURRENT SESSIONS
3.30pm-4.30pm
3.15pm-5.00pm
Australian War
Memorial
3.00pm-5.00pm
Tennis
Contact YRD
registration desk
for details
ANZGOG PRESENTATIONS
Session Chair: Assoc Prof Linda Mileshkin
(ASGO Members welcome or optional free afternoon)
Federation North Ballroom
2nd Half Brachytherapy
Workshop
Session Chair:
Dr Pearly Khaw
Assembly Room
NATIONAL OVARIAN
ACTION PLAN
WORKSHOP
Mt Ainslee Room
ANZGOG Abstract Presentations
1 LINDA MILESHKIN:
Abs 26
ANZGOG 06-02: A phase II trial of adjuvant chemotherapy
and chemoradiation following surgery for high-risk endometrial
cancer - updated survival results and patterns of relapse.
2 PETER FONG:
Abs 27
Adult granulosa cell tumours (GCT): 56 years of
clinicopathological outcomes including FOXL2 mutational
status.
3 NICOLE KINNANE:
Abs 28
Evaluation of the gynaecology basic sexual health assesment
questions incuded in the supportive needs screening tool.
4 ANNE LONG:
Abs 29
Quality of reporting of patient rated outcomes (PROs) in
ovarian cancer clinical trials: A Systematic Review.
5 ADNAN NAGRIAL:
Abs 30
Duration of systemic therapy for ovarian cancer: A systematic
review and meta-analysis.
6 DANNY RISCHIN:
Abs 31
A phase I study of the vascular disrupting agent BNC105P in
combination with gemcitabine-carboplatin in platinum sensitive
ovarian cancer patients in first or second relapse.
SPEAKER: ASSOC PROF
AKILA VISWANATHAN
Part I - Gynaecological
Oncologists
(Invitation only)
Sponsored by:
Session Chair:
Ms Alison Amos,
CEO, Ovarian Cancer
Australia
Co Chair:
Ms Alison Evans,
Zest Health Strategies
Sponsored by:
4.30pm-5.30pm
DR JIM COWARD
Outline 16
Targeting inflammation to overcome radiation and chemo
resistance in Gynaecological Cancer
5.00pm-5.30pm
ANZGOG - MR RICHARD DU ABREU LOURENCO
CREST - Health Economics
5.30pm-7.30pm
Award Winning Movie N.E.D - No Evidence of Disease | Federation South Ballroom
Join us for a glass of wine and inspiration. Meet lead singer Dr Joanie Hope from Alaska at the screening of the Award
Winning Movie - N.E.D. – No Evidence of Disease. ANZGOG is hosting this event about a group of musicians who are
also gynaecological oncologists in the USA – their music, their lives, their patients.
FREE EVENING IN CANBERRA
Outline 17
2014 Combined Scientific Meeting
Progress through collaboration and innovation
THE PROGRAM
SATURDAY, 29th MARCH
Time
Session
8.30am-12.00pm
JOINT PLENARY SESSION 3
Session Co-Chairs: Dr Jeff Goh & Dr Deb Neesham
Federation Ballroom
8.30am-10.30am
TUMOUR BOARD PANEL SESSION
Pathology: Dr Jan Pyman
Radiation Oncology: Assoc Prof Akila Viswanathan
Surgical: Prof Lynette Denny
Medical Oncology: Prof Jonathan Ledermann
DR LUIZA PECULIS:
Stage IB2 adenosquamous cervical cancer diagnosed at 19 weeks gestation
10.30am-11.00am
Morning Tea | Exhibition Area
11.00am-11.30am
PROF JONATHAN LEDERMANN
Keynote Address - Role of PARPi in high grade serous ovarian cancer
Outline 18
Abs 32
Outline 19
Sponsored by:
11.30am-12.00pm
PROF LYNETTE DENNY
Keynote Address - Inequities in care and its impact on cancer control
Outline 20
12.00pm-12.05pm
OFFICIAL CLOSE ANZGOG ASGO COMBINED ANNUAL SCIENTIFIC MEETING
Dr Alison Brand, ANZGOG Chair
Federation Ballroom
12.05pm-1.00pm
Lunch for ASGO Members | Exhibition Area
ANZGOG Conference Ends (except for invitees to National Ovarian Cancer Action Plan)
ASGO Members continue to next session
1.00pm-5.00pm
CONCURRENT SESSIONS
ASGO PLENARY SESSIONS
Federation South Ballroom
NATIONAL OVARIAN
ACTION PLAN WORKSHOP
Federation North Ballroom
1.00pm-1.30pm
DR JAN PYMAN
Outline 21
Immunohistochemistry for MSI in Uterine Cancer: Not so straightforward
1.30pm-3.00pm
ASGO Surgeons Corner and Surgical Dilemmas
Session Chair: Prof Tom Jobling
Outline 22
Part II - Other cancer
specialists
(Invitation only - not for CGO’s)
1 MURAD AL AKER:
Describing a technique of intra peritoneal chemotherapy port
placement during the interval period using a single incision.
2 NAVEN CHETTY:
A Laparoscopic approach to the retroperitoneal space.
3 SURGICAL DILEMAS:
Disasters that have occurred - presented by ASGO Members
4 ASSOC PROF ROB ROME
Dataprojector presentation
Abs 33
3.00pm-3.15pm
Afternoon Tea | Exhibition Area
3.15pm-5.00pm
ASGO ANNUAL GENERAL MEETING
Federation South Ballroom
7.00m-11.00pm
ASGO BLACK TIE DINNER | The Boat House by the Lake
(ASGO members and by invitation)
22
Abs 34
Session Chair:
Ms Alison Amos, CEO, Ovarian
Cancer Australia
Co Chair:
Ms Alison Evans,
Zest Health Strategies
Sponsored by:
`